Clinical Trials Browser

Phase 1/2 × ocrelizumab × Clear all

NCT02723071 2016-03-30

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Phase 1/2 Completed

Lymphoma, Non-Hodgkin